Among these were 6 members of the polycistronic miR-17-92 cluster, which are usually overexpressed and act as tumor promoters in a BCR/ABL- and c-myc-dependent manner in CML [36–38]. Here, MYC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.